SELLAS Life Sciences Group (SLS) Total Current Liabilities: 2011-2024
Historic Total Current Liabilities for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $10.6 million.
- SELLAS Life Sciences Group's Total Current Liabilities fell 9.56% to $10.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.6 million, marking a year-over-year decrease of 9.56%. This contributed to the annual value of $13.7 million for FY2023, which is 11.47% down from last year.
- As of Q3 2024, SELLAS Life Sciences Group's Total Current Liabilities stood at $10.6 million, which was down 11.89% from $12.0 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Total Current Liabilities peaked at $15.5 million during Q4 2022, and registered a low of $3.6 million during Q1 2020.
- Over the past 3 years, SELLAS Life Sciences Group's median Total Current Liabilities value was $12.6 million (recorded in 2022), while the average stood at $12.9 million.
- In the last 5 years, SELLAS Life Sciences Group's Total Current Liabilities crashed by 59.61% in 2021 and then skyrocketed by 211.42% in 2022.
- SELLAS Life Sciences Group's Total Current Liabilities (Quarterly) stood at $12.3 million in 2020, then crashed by 59.61% to $5.0 million in 2021, then skyrocketed by 211.42% to $15.5 million in 2022, then dropped by 11.47% to $13.7 million in 2023, then fell by 9.56% to $10.6 million in 2024.
- Its Total Current Liabilities was $10.6 million in Q3 2024, compared to $12.0 million in Q2 2024 and $14.4 million in Q1 2024.